GILD
Gilead Sciences, Inc.Company with tickers: GILD
CIK
882095
CUSIP
375558103
Shares Outstanding
1,241,569,874
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $6,960,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $2,586,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $2,021,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $1.63 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $1.61 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |